Platinum, Palladium...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$49.97 -1.16 | -2.27%
06/19/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 154.08M | 0.00 | 94.32M | 79.60M |
| Operating Gains/Losses | 4.28M | 0.00 | 15.94M | 1.17M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -5.67M | -21.97M | -3.37M | -14.66M |
| (Increase) Decrease in Inventories | -11.53M | -10.00M | 1.53M | -3.47M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 36.76M | 51.34M | 6.25M | 21.36M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 10.28M | 15.15M | -6.76M | -2.61M |
| Other Non-Cash Items | -6.40M | 127.42M | 14.42M | 19.82M |
| Net Cash From Continuing Operations | 215.65M | 200.37M | 184.47M | 160.58M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 215.65M | 200.37M | 184.47M | 160.58M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -18.13M | -100.07M | -17.47M | -11.11M |
| Acquisitions | 0.00 | -200.66M | 0.00 | -92.18M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -232.42M | -439.54M | -222.70M | -417.03M |
| Issuance of Debt | 0.00 | 0.00 | 259.22M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 36.13M | 61.56M | 16.33M | 4.74M |
| Repayment of Long-Term Debt | -121.81M | -16.79M | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 8.87M | 18.08M | -22.56M | 235.00K |
| Net Cash From Financing Activities | -76.81M | 62.84M | 252.99M | 4.98M |
| Effect of Exchange Rate Changes | 0.00 | 985.00K | 890.00K | -234.00K |
| Net Change in Cash & Cash Equivalents | -93.58M | -175.35M | 215.65M | -251.71M |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorGARP Growers for Summer 2013
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
Latest CBST Headlines from TheStreet
- Cubist Rises On Unusually High Volume (CBST) 04.02.13 | 04:04 pm
- 'Mad Money' Lightning Round: Solar Capital Is a Winner 03.08.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Follow the Market Leaders 03.07.13 | 08:03 pm
- 5 Stocks Set to Soar on Bullish Earnings 01.22.13 | 02:01 pm
- FDA Places New Heart-Safety Hurdle in Path of Opioid Constipation Drugs 11.12.12 | 10:11 am
- Cubist Stock Hits New 52-Week High (CBST) 09.21.12 | 03:09 pm
- Cramer's 'Mad Money' Recap: When Progress Isn't Good 09.18.12 | 08:09 pm
- Cubist Stock Hits New 52-Week High (CBST) 09.13.12 | 02:09 pm
- Nektar Therapeutics Is a Short 09.12.12 | 07:09 am
- Cubist Reaches New 52-Week High (CBST) 09.04.12 | 01:09 pm
Press Releases for CBST
- Cubist Obtains Remaining Rights To Ceftolozane From Astellas - Business Wire 03.11.13 | 08:03 am
- Michael Tomsicek, Cubist CFO (Photo: Business Wire) - Business Wire 03.04.13 | 07:03 am
- FDA Grants QIDP And Fast Track Designations For Cubist’s Late-Stage Antibiotic Candidates - Business Wire 02.28.13 | 04:02 pm
- Cubist Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 08:02 am
- Cubist Announces Exclusive Option To Acquire Adynxx - Business Wire 02.25.13 | 08:02 am
- Cubist To Present At February Investor Conferences - Business Wire 01.29.13 | 08:01 am
- Cubist Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 01.23.13 | 04:01 pm
- Thomas J. DesRosier (Photo: Business Wire) - Business Wire 01.08.13 | 08:01 am
- Cubist Announces Full-Year 2012 Revenues And Provides Business Update - Business Wire 01.07.13 | 07:01 am
- Heptares Partners With Cubist To Research New Medicines Targeting GPCRs - PR Newswire 01.07.13 | 07:01 am
Partner Headlines for CBST
- Encouraging Data on Novartis' Gilenya - Analyst Blog - Zacks 06.14.13 | 10:06 pm
- FDA Accepts Omeros' IND for OMS824 - Analyst Blog - Zacks 05.29.13 | 01:05 am
- NPS Pharma Prices Offering - Analyst Blog - Zacks 05.24.13 | 01:05 am
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals Following Data on New Drug - Benzinga 05.21.13 | 09:05 am
- Jump On Board With These 2 Companies - Seeking Alpha 04.22.13 | 09:04 am
- Revenues Decline at Alnylam - Analyst Blog - Zacks 11.07.12 | 09:11 am
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Stocks Tumble On Disappointing Earnings Reports - Investor's Business Daily 10.19.12 | 04:10 pm
- Stocks Hit Fresh Intraday Lows; Google Reverses Lower - Investor's Business Daily 10.19.12 | 03:10 pm
